Targeting myelin lipid metabolism as a potential therapeutic strategy in a model of CMT1A neuropathy

2018 | journal article. A publication with affiliation to the University of Göttingen.

Jump to: Cite & Linked | Documents & Media | Details | Version history

Cite this publication

​Targeting myelin lipid metabolism as a potential therapeutic strategy in a model of CMT1A neuropathy​
Fledrich, R. ; Abdelaal, T.; Rasch, L.; Bansal, V.; Schütza, V.; Brügger, B. & Lüchtenborg, C. et al.​ (2018) 
Nature Communications9(1).​ DOI: https://doi.org/10.1038/s41467-018-05420-0 

Documents & Media

s41467-018-05420-0.pdf4.17 MBAdobe PDF

License

Published Version

Attribution 4.0 CC BY 4.0

Details

Authors
Fledrich, R. ; Abdelaal, T.; Rasch, L.; Bansal, V.; Schütza, V.; Brügger, B.; Lüchtenborg, C.; Prukop, T. ; Stenzel, J.; Rahman, R. U.; Hermes, D.; Ewers, D.; Möbius, W. ; Ruhwedel, T.; Katona, I.; Weis, J.; Klein, D.; Martini, R.; Brück, W. ; Müller, W. C.; Bonn, S. ; Bechmann, I.; Nave, K. A. ; Stassart, R. M.; Sereda, M. W. 
Issue Date
2018
Journal
Nature Communications 
eISSN
2041-1723
Language
English

Reference

Citations


Social Media